those children's parents might want to look at these results first: this is an excellent post- for some this will be the 1st time reading this evidence- for others, it will be a review of past atrocities
Dr. Carl Heneghan The Daily Sceptic 27 Jun 2024 The devastating charge sheet against Pfizer
We've extracted the main points from the Kansas City Attorney General's legal report on the case against Pfizer that we first mentioned in 'Due Process' — all quotes are taken verbatim.
This is a lengthy post, and we'd recommend having an anger management strategy to hand while reading. If you are making a comment, use the numbering to highlight which points you are referring to, and do let us know if we've missed anything.
1. Pfizer misled the public.
- In May 2021, Pfizer advertised to Kansans on Facebook about its "life-saving vaccines" and its "cures". Upon information and belief, Pfizer intended for Kansans to think of its COVID-19 vaccine when it discussed "life-saving vaccines" and "cures". Pfizer ran three different ads between May 4th 2021 and June 1st 2021 that received 165,000 to 190,000 impressions.
- Pfizer received emergency use authorisation for its COVID-19 vaccine in individuals 16 years of age and older on December 11th 2020.
- Pfizer received FDA approval on August 23rd 2021. From 2021 to 2023, Pfizer received emergency use authorisations in children from six months to 15 years of age.
2. Pfizer used confidentiality agreements to conceal critical data relating to the safety and effectiveness of its COVID-19 vaccine.
- Pfizer effectively had a veto over the federal Government's communications.
3. Pfizer used its confidentiality agreements with the U.S. Government and others to conceal, suppress and omit material facts relating to Pfizer's COVID-19 vaccine, including the safety and efficacy of the vaccine.
4. Pfizer used an extended study timeline to conceal critical data - the study was repeatedly delayed.
- Pfizer planned to provide researchers with access to patient-level data and full clinical study reports 24 months after study completion. Protocol C4591001
- Pfizer estimated that it would complete the study by January 27th 2023, but that estimated date fell back to February 2024 because of a late vaccination of a single study participant (out of 44,000 participants).
- Pfizer's control of the data allowed the company to selectively publish results for which the underlying data could not be independently evaluated.
5. Pfizer says it will make data from vaccine trials approved in the U.S. available 18 months after the primary study completion date. Pfizer, Data Access Requests.
- Upon information and belief, Pfizer has still not made its complete study data available to researchers.
6. The FDA did not make the safety and effectiveness data for Pfizer's COVID-19 vaccine immediately available.
- The FDA denied expedited processing of PHMPTA's FOIA request and claimed in litigation that it would take 55 years — until 2076.
- In January 2022, a federal judge rejected the FDA's proposed production of 500 pages per month and ordered the FDA to instead produce 55,000 pages per month.
7. Pfizer destroyed the vaccine control group.
- Pfizer planned to follow COVID-19 vaccine study participants, both vaccine and placebo recipients for 24 months to monitor the safety and effectiveness of its vaccine.
- Once the FDA approved Pfizer's COVID-19 vaccine through an emergency use authorisation in December 2020, Pfizer unblinded the study participants and offered vaccine placebo recipients the option to receive the Pfizer COVID-19 vaccine.
- Only 1,544 placebo participants had not received the vaccine as of March 13th 2021, just 7% of the original placebo group.
8. In its press release announcing emergency use authorisation of its COVID-19 vaccine, Pfizer did not disclose that it had excluded immunocompromised individuals from its COVID-19 vaccine trials.
- Instead, in "Important Safety Information" in its press release, Pfizer noted that [i]mmunocompromised persons, including individuals receiving immunosuppressant therapy, may have a diminished immune response to the Pfizer BioNTech COVID-19 Vaccine.
9. Pfizer knew its COVID-19 vaccine was connected to serious adverse events, including myocarditis and pericarditis.
- Pfizer maintained its own adverse events database that "contain[ed] cases of [adverse events (AEs)] reported spontaneously to Pfizer, cases reported by the health authorities, cases published in the medical literature, cases from Pfizer-sponsored marketing programmes, non-interventional studies and cases of serious AEs reported from clinical studies regardless of causality assessment.
- Upon information and belief, Pfizer's adverse events database contained more adverse event data than VAERS because it included both information in VAERS and information not in VAERS.
10. The United States military detected a safety signal for myocarditis.
- In early 2021, the U.S. military noticed cases of myocarditis in male military members occurring within four days of administration of Pfizer's COVID-19 vaccine.When the Department of Defence reviewed its health system data for 2021, it found that "[t]hose who were recently vaccinated had a rate ratio that showed their incidences of myocarditis and pericarditis were 2.6 and 2.0 times higher compared to those who were never vaccinated".
- On March 3rd 2021, Israel's Ministry of Health contacted the CDC about myocarditis and pericarditis connected to Pfizer's COVID-19 vaccine: "We are seeing a large number of myocarditis and pericarditis cases in young individuals soon after Pfizer COVID-19 vaccine. We would like to discuss the issue with a relevant expert at CDC."
- Upon information and belief, Pfizer had knowledge of the medical reports in Israel related to its vaccine and myocarditis and pericarditis because Israel agreed to share medical data with Pfizer.
- At the time of Pfizer Chairman and CEO Dr. Bourla's January 18th 2023 denial of any safety signals, the CDC's website reported that "[d]ata from multiple studies show a rare risk for myocarditis and/or pericarditis following receipt of mRNA COVID-19 vaccines".
- According to a leaked confidential February 2022 Pfizer document, "[s]ince April 2021, increased cases of myocarditis and pericarditis have been reported in the United States after mRNA COVID-19 vaccination (Pfizer-BioNTech and Moderna), particularly in adolescents and young adults (CDC 2021)".
1. After Pfizer obtained FDA approval through emergency use authorisation to provide its COVID-19 vaccine to 12-15-year-olds in August 2021, Pfizer decided to study "how often" its vaccine may cause myocarditis or pericarditis in children by testing 5-16 year-olds for troponin I.
- Pfizer warned children participants that after receiving Pfizer's COVID-19 vaccine,"[y]ou might get chest pain, shortness of breath, or feelings of having a fast-beating, fluttering or pounding heart. You may need to come in to see the study doctor for further assessments if you have these symptoms".
- Pfizer press releases did not disclose an increased risk of myocarditis from Pfizer's COVID-19 vaccine until November 2021. Posts falsely claim Pfizer "officially admits" heart inflammation is COvid jab side-effect in 2023.
- Upon information and belief, at the time of Pfizer Chairman and CEO Dr. Bourla's January 2023 representation that Pfizer had not observed a single safety signal related to Pfizer's COVID-19 vaccine, Pfizer was aware of a safety signal relating to myocarditis and pericarditis.
12. Upon information and belief, Pfizer also detected a safety signal relating to strokes.
- Days before Pfizer Chairman and CEO Dr. Bourla denied any safety signal, the CDC's and FDA's "surveillance system flagged a possible link between the new Pfizer-BioNTech bivalent COVID-19 vaccine and strokes in people aged 65 and over.
- Although CDC later suggested a link was "very unlikely", an FDA study found that individuals 85 years or older who received both a flu vaccine and Pfizer's COVID-19 vaccine "saw a 20% increase in the risk of ischemic stroke".
13. Pfizer's knowledge of a safety signal for increased fatalities
- Upon information and belief, Pfizer also detected a safety signal relating to deaths. As of February 28th 2021, Pfizer's adverse events database contained 1,223 fatalities after taking Pfizer's COVID-19 vaccine.
14. Pfizer only tested the booster shot on 12 trial participants who were in the 65 to 85 year-old age range.
- Pfizer should not have represented that the booster was "safe" for 65 to 85 year-olds after only testing 12 trial participants in that age range.
Expand full comment
